Curtis Ruegg, EVP, Technical Operations at Revance Therapeutics, Inc. (RVNC), sold 1,500 shares at $18.61 ($28K) on 2015-03-17, disclosed to the SEC on 2015-03-19.
Scheduled sale ($28k) by EVP, Technical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RVNC | SELL | 2016-04-13 | $19K | — | Filing → |
| RVNC | SELL | 2016-03-09 | $20K | — | Filing → |
| RVNC | SELL | 2016-02-10 | $18K | — | Filing → |